A model for familial exudative vitreoretinopathy caused by LPR5 mutations

被引:82
|
作者
Xia, Chun-Hong [1 ]
Liu, Haiquan [1 ]
Cheung, Debra [1 ]
Wang, Meng [1 ]
Cheng, Catherine [2 ,3 ]
Du, Xin [4 ]
Chang, Bo [5 ]
Beutler, Bruce [4 ]
Gong, Xiaohua [1 ,2 ,3 ]
机构
[1] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, UCSF Joint Bioengn Grad Program, Berkeley, CA 94720 USA
[4] Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA
[5] Jackson Lab, Bar Harbor, ME 04609 USA
关键词
D O I
10.1093/hmg/ddn047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have identified a mouse recessive mutation that leads to attenuated and hyperpermeable retinal vessels, recapitulating some pathological features of familial exudative vitreoretinopathy (FEVR) in human patients. DNA sequencing reveals a single nucleotide insertion in the gene encoding the low-density lipoprotein receptor-related protein 5 (LRP5), causing a frame shift and resulting in the replacement of the C-terminal 39 amino acid residues by 20 new amino acids. This change eliminates the last three PPP(S/T)P repeats in the LRP5 cytoplasmic domain that are important for mediating Wnt/beta-catenin signaling. Thus, mutant LRP5 protein is probably unable to mediate its downstream signaling. Immunostaining and three-dimensional reconstructions of retinal vasculature confirm attenuated retinal vessels. Ultrastructural data further reveal that some capillaries lack lumen structure in the mutant retina. We have also verified that LRP5 null mice develop similar alterations in the retinal vasculature. This study provides direct evidence that LRP5 is essential for the development of retinal vasculature, and suggests a novel role played by LRP5 in capillary maturation. LRP5 mutant mice can be a useful model to explore the clinical manifestations of FEVR.
引用
收藏
页码:1605 / 1612
页数:8
相关论文
共 50 条
  • [1] Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5
    Jiao, XD
    Ventruto, V
    Trese, MT
    Shastry, BS
    Hejtmancik, JF
    AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (05) : 878 - 884
  • [2] FAMILIAL EXUDATIVE VITREORETINOPATHY
    BERGEN, RL
    GLASSMAN, R
    ANNALS OF OPHTHALMOLOGY, 1983, 15 (03): : 275 - 276
  • [3] Familial Exudative Vitreoretinopathy
    Sizmaz, Selcuk
    Yonekawa, Yoshihiro
    Trese, Michael T.
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2015, 45 (04): : 164 - 168
  • [4] Familial Exudative Vitreoretinopathy
    Chen, Kuan-Jen
    Wang, Nan-Kai
    Wu, Wei-Chi
    JAMA OPHTHALMOLOGY, 2017, 135 (04)
  • [5] FAMILIAL EXUDATIVE VITREORETINOPATHY
    CRISWICK, VG
    SCHEPENS, CL
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1969, 68 (04) : 578 - &
  • [6] Familial Exudative Vitreoretinopathy
    Liche, Fatson
    Majji, Ajit B.
    OPHTHALMOLOGY, 2012, 119 (05) : 1093 - 1093
  • [7] FAMILIAL EXUDATIVE VITREORETINOPATHY
    BOPP, S
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1988, 193 (03) : 328 - 328
  • [8] Familial exudative vitreoretinopathy
    Finis, D.
    Stammen, J.
    Joussen, A. M.
    OPHTHALMOLOGE, 2010, 107 (07): : 683 - 691
  • [9] FAMILIAL EXUDATIVE VITREORETINOPATHY
    LAQUA, H
    ALBRECHT VON GRAEFES ARCHIV FUR KLINISCHE UND EXPERIMENTELLE OPHTHALMOLOGIE, 1980, 213 (02): : 121 - 133
  • [10] FAMILIAL EXUDATIVE VITREORETINOPATHY
    EBERT, EM
    MUKAI, S
    INTERNATIONAL OPHTHALMOLOGY CLINICS, 1993, 33 (02) : 237 - 247